OBJECTIVE: To examine how people with end-stage dementia have conveyed their wishes for end-of-life care in advance directives. METHOD: The documents of 123 residents of three Maryland nursing homes, all with end-stage dementia, were reviewed. RESULTS: More years of education and White race were significantly associated with having an advance directive. With the exceptions of comfort care and pain treatment, advance directives were used primarily to restrict, not request, many forms of care at the end of life. Decisions about care for end-stage conditions such as Alzheimer's dementia are less often addressed in these documents than for terminal conditions and persistent vegetative state. DISCUSSION: For advance directives to better reflect a person's wishes, discussions with individuals and families about advance directives should include a range of care issues in the settings of terminal illness, persistent vegetative state or end-stage illness. These documents should be reviewed periodically to make certain that they convey accurately the person's treatment preferences.
OBJECTIVE: To examine how people with end-stage dementia have conveyed their wishes for end-of-life care in advance directives. METHOD: The documents of 123 residents of three Maryland nursing homes, all with end-stage dementia, were reviewed. RESULTS: More years of education and White race were significantly associated with having an advance directive. With the exceptions of comfort care and pain treatment, advance directives were used primarily to restrict, not request, many forms of care at the end of life. Decisions about care for end-stage conditions such as Alzheimer's dementia are less often addressed in these documents than for terminal conditions and persistent vegetative state. DISCUSSION: For advance directives to better reflect a person's wishes, discussions with individuals and families about advance directives should include a range of care issues in the settings of terminal illness, persistent vegetative state or end-stage illness. These documents should be reviewed periodically to make certain that they convey accurately the person's treatment preferences.
Authors: D W Molloy; G H Guyatt; R Russo; R Goeree; B J O'Brien; M Bédard; A Willan; J Watson; C Patterson; C Harrison; T Standish; D Strang; P J Darzins; S Smith; S Dubois Journal: JAMA Date: 2000-03-15 Impact factor: 56.272
Authors: Ziad R Haydar; Alice J Lowe; Kellie L Kahveci; Wilson Weatherford; Thomas Finucane Journal: J Am Geriatr Soc Date: 2004-05 Impact factor: 5.562
Authors: Marja-Liisa Laakkonen; Kaisu H Pitkala; Timo E Strandberg; Saila Berglind; Reijo S Tilvis Journal: Gerontology Date: 2004 Jul-Aug Impact factor: 5.140
Authors: Nancy R Downing; Siera Goodnight; Sena Chae; Joel S Perlmutter; Michael McCormack; Elizabeth Hahn; Stacey K Barton; Noelle Carlozzi Journal: Am J Hosp Palliat Care Date: 2017-06-28 Impact factor: 2.500
Authors: Heather Ma; Rachel E Kiekhofer; Sarah M Hooper; Sarah Dulaney; Katherine L Possin; Winston Chiong Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160
Authors: Betty S Black; Linda A Fogarty; Hilary Phillips; Thomas Finucane; David J Loreck; Alva Baker; David M Blass; Peter V Rabins Journal: J Aging Health Date: 2009-03-05
Authors: Corinne Pettigrew; Rostislav Brichko; Betty Black; Maureen K O'Connor; Mary Guerriero Austrom; Maisha T Robinson; Allison Lindauer; Raj C Shah; Guerry M Peavy; Kayla Meyer; Frederick A Schmitt; Jennifer H Lingler; Kimiko Domoto-Reilly; Dorothy Farrar-Edwards; Marilyn Albert Journal: Int Psychogeriatr Date: 2019-07-16 Impact factor: 3.878
Authors: Grace W K Ho; Lauren Skaggs; Gayane Yenokyan; Anela Kellogg; Julie A Johnson; Mei Ching Lee; Katherine Heinze; Mark T Hughes; Daniel P Sulmasy; Joan Kub; Peter B Terry; Alan B Astrow; Jing Zheng; Lisa Soleymani Lehmann; Marie T Nolan Journal: Palliat Support Care Date: 2016-05-30